Hospital Corporation of America

What Hospital Corporation of America does

HCA Healthcare (legal entity C-HCA, Inc., NYSE: HCA), originally founded as Hospital Corporation of America in 1960, is one of the largest publicly traded healthcare providers in the United States, headquartered in Delaware. The company operates an integrated network of hospitals, clinics, and specialized care centers, generating revenue primarily through patient care delivery, hospital-based professional services, physician partnerships, and laboratory operations. Its pathology services division, established in 2010 as Forward Pathology Solutions and now branded HCA Healthcare Pathology Services, delivers centralized diagnostic services across 20 subspecialties including hematopathology, dermatopathology, cytopathology, and molecular pathology, supported by 200+ board-certified medical professionals and 100+ practice locations. Additional platform components include the Sarah Cannon Cancer Network for oncology, the MyHealthONE patient portal, the HCA Healthcare Research Institute for clinical research, and Graduate Medical Education programs for physician training.

The underlying service model is direct delivery through HCA's owned hospital and clinic network, supplemented by commercial clients and physician referral relationships. Marketing and brand presence is maintained through the corporate website, social media channels (Facebook, Instagram, LinkedIn, YouTube), publications (HCA Healthcare Today blog, magazine, Annual Impact Report), and physician referral networks. Customer segments span individual patients requiring complex diagnostic services, referring physicians and clinicians needing subspecialty consultation, and hospitals/clinics requiring comprehensive pathology operations support.

The technology stack is not specified in the source data; no AI/ML capabilities, APIs, SDKs, or proprietary technology platforms are disclosed. Core differentiation rests on talent density (200+ board-certified pathologists across 20 subspecialties), scale (100+ hospitals and practice locations), and an evidence-based, value-driven professional services model rather than on disclosed proprietary technology.

Name

Hospital Corporation of America

Legal name

C-HCA, Inc.

Website

https://fpshealthcare.com

Company type

Public

Founded year

1960

Operating status

Operating

Headcount range

1–10 employees

Short description

HCA Healthcare (C-HCA, Inc., NYSE: HCA) is a major US publicly traded healthcare provider operating hospitals, clinics, and specialized care centers. Its pathology division delivers diagnostic expertise via 200+ board-certified pathologists across 20 subspecialties, supporting 100+ hospitals and commercial clients.

Ownership category

akta.pro rank

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Distribution channels1 record

Marketing channels4 records

Core offering

Hospital Corporation of America (HCA Healthcare) operates a large network of hospitals and clinics delivering acute care, specialty, and outpatient healthcare services. Its Pathology Services division, originally established in 2010 as Forward Pathology Solutions, provides expert diagnostic pathology across 20 subspecialties through more than 200 board-certified pathologists serving over 100 hospitals, laboratories, and commercial clients. The company also operates the Sarah Cannon Cancer Network for oncology care and the MyHealthONE patient portal for digital health management.

Product overview

HCA Healthcare operates a comprehensive pathology services platform consisting of HCA Healthcare Pathology Services (originally established in 2010 as Forward Pathology Solutions) providing expert, timely and cost-effective pathology solutions to over 100 hospitals and clinics. The platform comprises multiple subspecialty services including Hematopathology, Dermatopathology, Cytopathology, and Molecular Pathology, delivered by a network of 200+ board-certified pathologists across 20 subspecialties. Additional offerings include the MyHealthONE patient portal for patient engagement and the Sarah Cannon Cancer Network for specialized oncology care. The organization delivers quality-driven, evidence and value-based pathology professional services.

Differentiator

Problem solved

Functional benefit

Brands

• HCA Healthcare Pathology Services: Provides expert, timely and cost-effective pathology solutions supporting over 100 hospitals and clinics
• Sarah Cannon Cancer Network
• MyHealthONE
• HCA Healthcare Research Institute
• Graduate Medical Education

Products and services

• HCA Healthcare Pathology Services Professional pathology services delivered through a network of 200+ board-certified pathologists across 20 subspecialties, supporting over 100 HCA Healthcare hospitals, laboratories, and commercial clients with quality-driven, evidence and value-based diagnostic services.
• Hematopathology Specialized hematopathology diagnostic services with board-certified specialists providing advanced testing regimens and collaborating with primary care clinicians to guide therapy for patients with leukemia and lymphoma.
• Dermatopathology Dermatopathology services staffed by fellowship-trained specialists providing diagnosis and treatment guidance for melanoma, non-melanoma skin cancers, cutaneous lymphomas, and inflammatory skin conditions.
• Cytopathology Cytopathology services with expert teams trained through a rigorous one-year study and intensive examination in addition to a pathology residency, offering diagnostic services that can help prevent patients from undergoing biopsies or more extensive surgery.
• Molecular Pathology Molecular pathology services that improve the ability to diagnose, treat, and follow cancer through collaboration with molecular pathologists, paving the way for personalized medicine approaches.
• Sarah Cannon Cancer Network Cancer care and oncology network providing specialized comprehensive cancer treatment services across HCA Healthcare facilities.
• MyHealthONE Patient portal and mobile application enabling patients to manage health records, schedule appointments, and access HCA Healthcare services online.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Universal Health Services: Large US hospital and behavioral health operator with comparable scale and multi-state acute care footprint. Relevant peer for benchmarking how a similarly sized hospital system sources and structures its pathology and laboratory services.
• Tenet Healthcare: Major US for-profit hospital operator with significant outpatient and ambulatory exposure. Comparable to HCA Healthcare at the parent level as a similarly scaled acute care system that also consumes large volumes of hospital-based pathology services.
• Community Health Systems: Large US hospital operator serving non-urban and mid-sized markets, comparable to HCA in scale and care delivery model. Useful peer for understanding how competing hospital systems procure or operate pathology services at similar scale.

Direct peers

• Quest Diagnostics: Largest independent clinical laboratory company in the US, providing anatomic and clinical pathology services to hospitals, physicians, and patients. Competes directly for hospital pathology contracts and reference work that HCA Healthcare Pathology Services also targets.
• PathGroup: Private, US-based pathology services provider delivering hospital-based anatomic and clinical pathology with a multi-subspecialty model. Closest pure-play peer to HCA Healthcare Pathology Services in terms of serving community hospitals with subspecialty reads.
• Sonic Healthcare: Global pathology and laboratory services provider with a substantial US footprint acquired via Aurora Diagnostics. Directly comparable multi-subspecialty, hospital-anchored pathology model with national coverage ambitions.
• Laboratory Corporation of America (Labcorp): Second-largest US clinical lab company with a sizable anatomic pathology business serving hospitals and health systems. Directly comparable business model of multi-subspecialty pathologist networks combined with high-volume reference lab infrastructure.
• NeoGenomics: Specialty oncology-focused pathology services company providing molecular and anatomic pathology to hospitals, oncology practices, and biopharma. Directly comparable in oncology and molecular pathology subspecialty work that HCA Healthcare Pathology Services also markets.

Emerging players

• ARUP Laboratories: Academic, nonprofit reference laboratory affiliated with the University of Utah, providing esoteric and subspecialty testing to hospitals nationwide. Comparable as a high-complexity reference partner hospitals use alongside their in-house pathology.
• Mayo Clinic Laboratories: Reference laboratory from Mayo Clinic offering specialty and esoteric testing to hospitals and health systems globally. Comparable as a high-end subspecialty reference partner whose menu overlaps with HCA's 20 subspecialty pathology offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/hcahealthcare
• Facebookfacebook.com/HCACare
• LinkedInlinkedin.com/company/vibracode
• Instagraminstagram.com/hcahealthcare

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hospital Corporation of America